Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2021

Open Access 01-06-2021 | Care

Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer

Authors: Lente L. Kroon, Janneke van Roij, Ida J. Korfage, An K. L. Reyners, Marieke H. J. van den Beuken-van Everdingen, Marien O. den Boer, Geert-Jan Creemers, Alexander de Graeff, Mathijs P. Hendiks, Jarmo C. B. Hunting, Wouter K. de Jong, Evelien J. M. Kuip, Hanneke W. M. van Laarhoven, Lobke van Leeuwen, Anne S. R. van Lindert, Caroline M. P.W. Mandigers, Peter Nieboer, Annemieke van der Padt-Pruijsten, Tineke J. Smilde, Dirkje W. Sommeijer, Martine F. Thijs, Marian A. Tiemessen, Allert H. Vos, Art Vreugdenhil, Philo T. Werner, Lia van Zuylen, Lonneke V. van de Poll-Franse, Natasja J. H. Raijmakers, on behalf of the eQuiPe study group

Published in: Journal of Cancer Survivorship | Issue 3/2021

Login to get access

Abstract

Purpose

Advance Care Planning (ACP) is positively associated with the quality of care, but its impact on emotional functioning is ambiguous. This study investigated the association between perceptions of ACP involvement and emotional functioning in patients with advanced cancer.

Methods

This study analyzed baseline data of 1,001 patients of the eQuiPe study, a prospective, longitudinal, multicenter, observational study on quality of care and quality of life in patients with advanced cancer in the Netherlands. Patients with metastatic solid cancer were asked to participate between November 2017 and January 2020. Patients’ perceptions of ACP involvement were measured by three self-administered statements. Emotional functioning was measured by the EORTC-QLQ-C30. A linear multivariable regression analysis was performed while taking gender, age, migrant background, education, marital status, and symptom burden into account.

Results

The majority of patients (87%) reported that they were as much involved as they wanted to be in decisions about their future medical treatment and care. Most patients felt that their relatives (81%) and physicians (75%) were familiar with their preferences for future medical treatment and care. A positive association was found between patients’ perceptions of ACP involvement and their emotional functioning (b=0.162, p<0.001, 95%CI[0.095;0.229]) while controlling for relevant confounders.

Conclusions

Perceptions of involvement in ACP are positively associated with emotional functioning in patients with advanced cancer. Future studies are needed to further investigate the effect of ACP on emotional functioning.

Trial registration number

NTR6584 Date of registration: 30 June 2017

Implications for Cancer Survivors

Patients’ emotional functioning might improve from routine discussions regarding goals of future care. Therefore, integration of ACP into palliative might be promising.
Literature
5.
go back to reference van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188–94. https://doi.org/10.1016/j.ejca.2011.04.034.CrossRefPubMed van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188–94. https://​doi.​org/​10.​1016/​j.​ejca.​2011.​04.​034.CrossRefPubMed
Metadata
Title
Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer
Authors
Lente L. Kroon
Janneke van Roij
Ida J. Korfage
An K. L. Reyners
Marieke H. J. van den Beuken-van Everdingen
Marien O. den Boer
Geert-Jan Creemers
Alexander de Graeff
Mathijs P. Hendiks
Jarmo C. B. Hunting
Wouter K. de Jong
Evelien J. M. Kuip
Hanneke W. M. van Laarhoven
Lobke van Leeuwen
Anne S. R. van Lindert
Caroline M. P.W. Mandigers
Peter Nieboer
Annemieke van der Padt-Pruijsten
Tineke J. Smilde
Dirkje W. Sommeijer
Martine F. Thijs
Marian A. Tiemessen
Allert H. Vos
Art Vreugdenhil
Philo T. Werner
Lia van Zuylen
Lonneke V. van de Poll-Franse
Natasja J. H. Raijmakers
on behalf of the eQuiPe study group
Publication date
01-06-2021
Publisher
Springer US
Keyword
Care
Published in
Journal of Cancer Survivorship / Issue 3/2021
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01020-y

Other articles of this Issue 3/2021

Journal of Cancer Survivorship 3/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine